LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Digital Marketing Business for Sale
Automotive Businesses for Sale
Bars, Pubs & Nightclubs for Sale
Hotels and Motels for Sale
Convenience Stores & Lotto Businesses For Sale
Vending & Kiosk Businesses for Sale
Construction & Landscaping Businesses for Sale
Cleaning & Janitorial Businesses for Sale
Farms & Vineyards for Sale
Fitness & Wellness Businesses for Sale
Post Office Franchises for Sale
Real Estate & Property Management Franchise for Sale
Healthcare & Medical Franchise Opportunities
Convenience Store & Lotto Franchises for Sale
Finance & Accounting Franchise Opportunities
Coffee, Bakery & Dessert Franchise Opportunities
Transport & Shipping Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Automotive Franchises for Sale
Senior Care Franchise for Sale
Places of Worship for Sale
Medical Buildings for Sale or Lease
Commercial Buildings for Sale or Lease
Retail Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Plazas for Sale
Industrial Units for Sale or Rent
Houses & Condos for Sale or Lease
Medical Office Spaces for Sale or Rent
Apartment Buildings for Sale
An email will be sent to registered email address.
Please select if you are: